Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Euro Surveill ; 22(28)2017 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-28749333

RESUMO

Between February and May 2017, two cases of invasive meningococcal disease caused by a new, rapidly expanding serogroup W meningococci variant were reported among students of an international university in Paris. Bacteriological investigations showed that isolates shared identical genotypic formula (W:P1.5,2:F1-1:cc11) and belonged to the South American/UK lineage. A vaccination campaign was organised that aimed at preventing new cases linked to potential persistence of the circulation of the bacteria in the students.


Assuntos
Infecções Meningocócicas/diagnóstico , Neisseria meningitidis Sorogrupo W-135/isolamento & purificação , Busca de Comunicante , Febre/etiologia , Genótipo , Humanos , Masculino , Infecções Meningocócicas/sangue , Infecções Meningocócicas/microbiologia , Tipagem Molecular , Neisseria meningitidis Sorogrupo W-135/genética , Paris , Sorogrupo , Estudantes , Sequenciamento Completo do Genoma , Adulto Jovem
2.
Eur J Public Health ; 27(2): 359-366, 2017 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-27452893

RESUMO

Background: Asbestos is known to be an independent risk factor for lung and pleural cancers. However, to date, little attention has been paid to the psychological effects of asbestos exposure among exposed subjects. The objectives of this study were to estimate the prevalence of anxious and depressive symptoms among >2000 French participants of the Asbestos-Related Diseases Cohort (ARDCO), 6 years after their inclusion, to identify the risk factors associated with those anxious and depressive symptoms and to evaluate the impact of the asbestos-risk perception. Methods: The ARDCO was constituted in four regions of France between October 2003 and December 2005, by including former asbestos workers. Between 2011 and 2012, participants of the ARDCO program were invited to undergo another chest CT scan 6 years after the previous scan. Participants were asked to complete questionnaires including asbestos exposure assessment, Hospital Anxiety and Depression Scale (HADS), asbestos-risk perception and self-perception of asbestos-related diseases. Results: Among the 2225 participants, 2210 fully completed questionnaires were collected and analyzed. The prevalence of symptoms of probable anxiety and probable depression was 19.7% and 9.9%, respectively. The risk of anxious and depressive symptoms was independently associated with self-perception of the intensity of asbestos exposure, asbestos-risk perception and self-perception of asbestos-related diseases. Conclusion: The results obtained in this large study confirm that previously asbestos-exposed subjects are likely to develop anxious and depressive symptoms. Finally, implications related to the prevention of anxiety and depression among asbestos-exposed workers is discussed.


Assuntos
Transtornos de Ansiedade/epidemiologia , Asbestose/epidemiologia , Asbestose/psicologia , Transtorno Depressivo/epidemiologia , Autoimagem , Idoso , Transtornos de Ansiedade/psicologia , Causalidade , Estudos de Coortes , Comorbidade , Transtorno Depressivo/psicologia , Feminino , França , Humanos , Masculino , Prevalência , Risco , Fatores de Risco , Inquéritos e Questionários
3.
Euro Surveill ; 21(10): 30156, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26987576

RESUMO

In 2013, 15 clusters of mumps were notified in France; 72% (82/114) of the cases had been vaccinated twice with measles-mumps-rubella vaccine. To determine whether the risk of mumps increased with time since the last vaccination, we conducted a case-control study among clusters in universities and military barracks. A confirmed case had an inflammation of a salivary gland plus laboratory confirmation in 2013. A probable case presented with inflammation of a salivary gland in 2013 either lasting for > 2 days or with epidemiological link to a confirmed case. Controls had no mumps symptoms and attended the same university course, student party or military barracks. We collected clinical and vaccination data via web questionnaire and medical records. We calculated adjusted odds ratios (aOR) using logistic regression. 59% (50/85) of cases and 62% (199/321) of controls had been vaccinated twice. The odds of mumps increased for twice-vaccinated individuals by 10% for every year that had passed since the second dose (aOR 1.10; 95% confidence interval (CI): 1.02-1.19; p = 0.02). Mumps immunity waned with increasing time since vaccination. Our findings contributed to the French High Council of Public Health's decision to recommend a third MMR dose during outbreaks for individuals whose second dose dates > 10 years.


Assuntos
Notificação de Doenças/estatística & dados numéricos , Surtos de Doenças , Vacina contra Caxumba/administração & dosagem , Vacina contra Caxumba/imunologia , Caxumba/epidemiologia , Caxumba/imunologia , Adolescente , Estudos de Casos e Controles , Feminino , França , Humanos , Masculino , Vacina contra Sarampo-Caxumba-Rubéola/administração & dosagem , Vacina contra Sarampo-Caxumba-Rubéola/imunologia , Caxumba/prevenção & controle , Vírus da Caxumba/genética , Vírus da Caxumba/isolamento & purificação , Estudantes/estatística & dados numéricos , Inquéritos e Questionários , Vacinação/estatística & dados numéricos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...